Nikoletta Carayannopoulos, DO
Orthopaedic Surgery · Houston, TXNPI 1174727747
Payments from drug & device makers
Across 146 payments — averaging $50.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medinc Of Texas$2K
- Synthes GmbH$2K
- Stryker$2K
- Globus Medical$574
- Amgen$281
- Johnson & Johnson$279
- plus $876 from 22 others
What the payments were for
- Speaking & faculty fees$1,50020%
- Food & beverage$3,88253%
- Education$1,98827%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medinc Of Texas | 5 | $2,132 |
| Synthes GmbH | 2 | $1,628 |
| Stryker(2 entities) | 36 | $1,599 |
| Globus Medical | 24 | $574 |
| Amgen(2 entities) | 28 | $281 |
| Johnson & Johnson(2 entities) | 12 | $279 |
| Smith+Nephew | 4 | $94 |
| Bioventus LLC | 4 | $87 |
| Ossur Americas, Inc. | 5 | $61 |
| Cerapedics Inc. | 2 | $59 |
| Pacira Therapeutics, Inc. | 3 | $57 |
| Organogenesis Inc. | 3 | $56 |
| Boston Scientific | 1 | $55 |
| Acera Surgical, Inc. | 2 | $54 |
| Nalu Medical, Inc. | 1 | $44 |
| Heraeus Medical, LLC. | 1 | $42 |
| Anika Therapeutics, Inc. | 1 | $34 |
| Abbott | 2 | $32 |
| Orthalign Inc | 1 | $30 |
| Kerecis Limited | 1 | $26 |
| Curonix LLC | 1 | $24 |
| Fidia Pharma USA Inc. | 1 | $22 |
| Acell, Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $17 |
| Radius Health, Inc. | 1 | $16 |
| Arteriocyte Medical Systems, Inc. | 1 | $16 |
| Innovation Technologies Inc | 1 | $14 |
How this compares
$7,370 in reported general payments places this provider in the 55th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 170 | $1,760 |
| Celecoxib | 31 | $968 |
| Methocarbamol | 37 | $609 |
| Meloxicam | 128 | $282 |
| Methylprednisolone | 22 | $162 |
| Cyclobenzaprine Hcl | 13 | $155 |
| Tizanidine Hcl | 25 | $134 |
| Tramadol Hcl | 13 | $28 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Houston
- Stefan KreuzerHouston$7M
- Tiffany HuynhHouston$4.6M
- Stephen IncavoHouston$4.3M
- Thomas EdwardsHouston$4.3M
- Adam FreedhandHouston$1.8M
- Jeffrey KozakHouston$1.1M
- Travis HansonHouston$1M
- David VanderweideHouston$741K
- Thomas TanousHouston$698K
- Alan RechterHouston$605K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.